2017
DOI: 10.1016/j.ejmech.2016.10.036
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
18
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(21 citation statements)
references
References 39 publications
3
18
0
Order By: Relevance
“…To investigate the interaction mode of compounds 1 and 1q with AChE, a molecular modeling study was carried out using Molecular Operating Environment ( moe ) software and the PDB structure of 1EVE was taken from the RCSB Protein Data Bank for the docking procedure. Previous studies showed that two methoxy groups of donepezil interacted with Trp286 of acetylcholinesterase through hydrogen bond . In the present study, the methoxy group at the C7 position of compound 1 interacted with Trp286 to form a hydrogen bond, while the methoxy group at the C8 position could not form a hydrogen bond with Trp286 due to steric hindrance (Figure b).…”
Section: Resultssupporting
confidence: 43%
“…To investigate the interaction mode of compounds 1 and 1q with AChE, a molecular modeling study was carried out using Molecular Operating Environment ( moe ) software and the PDB structure of 1EVE was taken from the RCSB Protein Data Bank for the docking procedure. Previous studies showed that two methoxy groups of donepezil interacted with Trp286 of acetylcholinesterase through hydrogen bond . In the present study, the methoxy group at the C7 position of compound 1 interacted with Trp286 to form a hydrogen bond, while the methoxy group at the C8 position could not form a hydrogen bond with Trp286 due to steric hindrance (Figure b).…”
Section: Resultssupporting
confidence: 43%
“…), again emphasizing the importance of the crystal structure of the human enzyme for the design of improved lead compounds based on donepezil (van Greunen et al . ).…”
Section: Structural Studies On Human Acetylcholinesterasementioning
confidence: 97%
“…Additionally, nonhepatotoxicity, blood-brain barrier (BBB) permeability, a single daily dose, and the least side effects provide advantages for donepezil when compared to other AChE inhibitors [5]. Therefore, donepezil analogs have been studied more broadly [6][7][8].…”
Section: Introductionmentioning
confidence: 99%